");$(".close-btn").click(function() { $(this).parent().fadeOut(800);});setTimeout(showpanel1, 5000);function showpanel1() { $(".close-btn").css("bottom","79px");}'); } }); } var menu = new cbpTooltipMenu(document.getElementById('cbp-tm-menu')); $(document).ready(function () { if ($(".ad-box").length) { $(".pushhead").addClass("right-space"); } });");$(".close-btn").click(function() { $(this).parent().fadeOut(800);});setTimeout(showpanel1, 5000);function showpanel1() { $(".close-btn").css("bottom","79px");}

Breaking News

Sign MOU for the discovery and development of novel drugs.

07.14.22

Through this agreement, both companies will cooperate in the overall development process, such as discovery, manufacturing and clinical trials of antibody and cell treatments, and related research and service projects.

DAAN Bio Therapeutics has conducted single cell transcriptomic and proteomic biomarker analysis through its own analysis platform using tissues secured from solid cancer patients along with DAAN Cancer Research Institute and Yonsei New Il Han Institute for Integrative Cancer Research.

Accordingly, DAAN Bio Therapeutics signed a contract manufacturing organization (CMO) service through GenScript ProBio to develop antibodies that specifically bind to the discovered target material, and established its own bispecific antibody production pipeline using antibodies derived through GMP production.

I hope this strategic partnership with DAAN Bio Therapeutics will be of great support as a global partner in accelerating the development of DAAN's antibody and cell therapy through the GenScript ProBio's one-stop CDMO service platform, said Brian Min, CEO, GenScript ProBio.

Byoung Chul Cho, co-founder and CEO, DAAN Bio Therapeutics, said, This strategic cooperation will be an opportunity to revitalize the development of antibody and cell therapy that control unique cancer treatment targets secured by DAAN Bio Therapeutics using GenScript ProBio's qualified and competitive technologies.

Through this partnership, both GenScript ProBio and DAAN Bio Therapeutics will continue their cooperation more closely with each other to develop subsequent pipelines of DAAN Bio Therapeutics, such as antibody drug and cell therapy.

See the original post:
GenScript ProBio, DAAN Bio Therapeutics Enter Cell and Gene Therapy Partnership - Contract Pharma

Comments are closed.